Market Overview

Sirona Biochem Hires Investor Relations Firm Consulting to Increase Awareness in US

Sirona Biochem (OTC: SRBCF) announced today it has hired Consulting for Strategic Growth 1 (CFSG1), an investor relations and corporate development firm based in New York City. CFSG1 has been hired to increase awareness of Sirona Biochem in the U.S. marketplace. "Now that we are trading on the OTCQX in the U.S., it's important to have strong, credible U.S. representation to communicate the value of Sirona Biochem and the excellent progress we have been making," said Neil Belenkie, Sirona Biochem Chief Executive Officer. "CFSG1 has proven expertise in taking emerging growth companies to the forefront of the American investor marketplace and we look forward to working with their team to share Sirona Biochem's story."Stan Wunderlich, Chairman and CEO of CFSG1, commented, "Sirona Biochem is changing the nature of carbohydrate-based chemistry and is delivering new, powerful compounds that have the potential to change the landscape of the drug, cosmetic and biochemistry industries. We are excited to be a partner in this venture and believe a great opportunity exists for this company in the public arena."Sirona Biochem will pay CFSG1 US$8,750.00 per month during a six month term starting February 1, 2013 and,

See full press release

Posted-In: News Guidance Contracts Management Global

 

Most Popular

Related Articles (SRBCF)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free